Implementation of Coordinated Global Serotype 2 Oral Poliovirus Vaccine Cessation: Risks of Potential Non-Synchronous Cessation

BMC Infectious Diseases - United Kingdom
doi 10.1186/s12879-016-1536-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC